Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal IRS-1 (Ab-312) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human IRS-1 around the phosphorylation site of serine 312 (A-T-SP-P-A). |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Rabbit Polyclonal antibody to RAC1 (ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1))
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 1 and 196 of RAC1 (Uniprot ID#P63000 isoform B) |
Calneuron-1 / CALN1 Rabbit Polyclonal (N-Terminus) Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Calneuron-1 / CALN1 antibody was raised against a 16 amino acid peptide near the amino terminus of human CaBP8. |
Rabbit polyclonal IL1R Antibody (C-term E487)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL1R antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-503 amino acids from the C-terminal region of human IL1R. |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit polyclonal GRB2 (Ab-159) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GRB2 around the phosphorylation site of serine 159 (K-S-SP-A-P). |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Anti-AOX1 rabbit polyclonal antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 300 amino acids of human aldehyde oxidase 1 |
Anti-SOX2 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 250 amino acids of human SRY (sex determining region Y)-box 2 |
Anti-KLK5 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 279-293 amino acids of Human kallikrein-related peptidase 5 |
Anti-TPM2 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 188-207 amino acids of Human tropomyosin 2 (beta) |
Anti-SEMA3D Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 627-642 amino acids of human sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
Anti-ADAMTS16 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 1076-1090 amino acids of human ADAM metallopeptidase with thrombospondin type 1 motif, 16 |
Anti-SLC44A1 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 433-447 amino acids of Human solute carrier family 44, member 1 |
Anti-PAK7 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 300 amino acids of human p21 protein (Cdc42/Rac)-activated kinase 7p21 protein (Cdc42/Rac)-activated kinase 7 |
Anti-CEBPA Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 82-100 amino acids of Human CCAAT/enhancer binding protein (C/EBP), alpha |
Anti-BID Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Full length fusion protein |
Anti-NLRP3 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 1-301 amino acids of human NLR family, pyrin domain containing 3 |
Anti-GAS6 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 690-705 amino acids of Human growth arrest-specific 6 |
Anti-SPP1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 17-300 amino acids of human secreted phosphoprotein 1 |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- IHC
Antibody Hosts
- Rabbit
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Citations
- Yes
Availabilities
- In Stock
Filter by
Target Symbol
- BAX (2)
- ACTG2 (1)
- ADAMTS16 (1)
- ANTXR1 (1)
- AOX1 (1)
- BAG3 (1)
- BID (1)
- CALN1 (1)
- CCNE1 (1)
- CDK6 (1)
- CEBPA (1)
- COL2A1 (1)
- CSTB (1)
- CTNNB1 (1)
- CYP19A1 (1)
- CYP3A4 (1)
- DIABLO (1)
- FTH1 (1)
- GAB2 (1)
- GAD1 (1)
- GAS6 (1)
- GPD2 (1)
- HAP1 (1)
- HOXC8 (1)
- HSP90AA1 (1)
- IL1R1 (1)
- IRF3 (1)
- IRS1 (1)
- JAK1 (1)
- KDR (1)
- KLK5 (1)
- MSH6 (1)
- MYCN (1)
- NGF (1)
- NLRP3 (1)
- NPHS2 (1)
- NR3C1 (1)
- PAK2 (1)
- PAK5 (1)
- PFKFB2 (1)
- POU5F1 (1)
- RAC1 (1)
- RELA (1)
- RHBDD2 (1)
- SCARB1 (1)
- SCNN1B (1)
- SDC4 (1)
- SEMA3D (1)
- SLC18A2 (1)
- SLC2A1 (1)
- SLC44A1 (1)
- SLC8A3 (1)
- SNAP23 (1)
- SNAP29 (1)
- SOX2 (1)
- SPP1 (1)
- SSTR3 (1)
- ST6GAL1 (1)
- STAT3 (1)
- TP53INP1 (1)
- TPM2 (1)
- TRAF3IP1 (1)
- TRPV4 (1)
- TUBB3 (1)
Isotypes
Knockout (KO) Validation
Modifications
Families
- Druggable Genome (46)
- Transmembrane (21)
- Transcription Factors (10)
- ES Cell Differentiation/IPS (7)
- Protein Kinase (5)
- Secreted Protein (5)
- Stem cell - Pluripotency (3)
- Adult stem cells (2)
- Cancer stem cells (2)
- Embryonic stem cells (2)
- Induced pluripotent stem cells (2)
- P450 (2)
- Protease (2)
- GPCR (1)
- Ion Channels: Transient receptor potential (1)
- Nuclear Hormone Receptor (1)
- Stem cell relevant signaling - DSL/Notch pathway (1)
Pathways
- Pathways in cancer (14)
- Focal adhesion (7)
- Apoptosis (6)
- Neurotrophin signaling pathway (6)
- Colorectal cancer (5)
- MAPK signaling pathway (5)
- Metabolic pathways (5)
- Pancreatic cancer (5)
- p53 signaling pathway (5)
- Adipocytokine signaling pathway (4)
- Amyotrophic lateral sclerosis (ALS) (4)
- Axon guidance (4)
- Prostate cancer (4)
- Renal cell carcinoma (4)
- Toll-like receptor signaling pathway (4)
- Acute myeloid leukemia (3)
- Chemokine signaling pathway (3)
- Chronic myeloid leukemia (3)
- ECM-receptor interaction (3)
- Huntington's disease (3)
- NOD-like receptor signaling pathway (3)
- Regulation of actin cytoskeleton (3)
- Small cell lung cancer (3)
- T cell receptor signaling pathway (3)
- Adherens junction (2)
- B cell receptor signaling pathway (2)
- Cell cycle (2)
- Cytokine-cytokine receptor interaction (2)
- Cytosolic DNA-sensing pathway (2)
- Drug metabolism - cytochrome P450 (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Jak-STAT signaling pathway (2)
- Leukocyte transendothelial migration (2)
- Natural killer cell mediated cytotoxicity (2)
- Neuroactive ligand-receptor interaction (2)
- Pathogenic Escherichia coli infection (2)
- Prion diseases (2)
- RIG-I-like receptor signaling pathway (2)
- SNARE interactions in vesicular transport (2)
- VEGF signaling pathway (2)
- Viral myocarditis (2)
- Wnt signaling pathway (2)
- Alanine (1)
- Alzheimer's disease (1)
- Androgen and estrogen metabolism (1)
- Antigen processing and presentation (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Basal cell carcinoma (1)
- Butanoate metabolism (1)
- Calcium signaling pathway (1)
- Cardiac muscle contraction (1)
- Cell adhesion molecules (CAMs) (1)
- Dilated cardiomyopathy (1)
- Drug metabolism - other enzymes (1)
- Endocytosis (1)
- Endometrial cancer (1)
- Fructose and mannose metabolism (1)
- Gap junction (1)
- Glioma (1)
- Glycerophospholipid metabolism (1)
- Hematopoietic cell lineage (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Insulin signaling pathway (1)
- Linoleic acid metabolism (1)
- Melanogenesis (1)
- Melanoma (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- Mismatch repair (1)
- N-Glycan biosynthesis (1)
- Nicotinate and nicotinamide metabolism (1)
- Non-small cell lung cancer (1)
- Oocyte meiosis (1)
- Parkinson's disease (1)
- Porphyrin and chlorophyll metabolism (1)
- Progesterone-mediated oocyte maturation (1)
- Retinol metabolism (1)
- Taurine and hypotaurine metabolism (1)
- Thyroid cancer (1)
- Tight junction (1)
- Tryptophan metabolism (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- Tyrosine metabolism (1)
- Valine (1)
- Vascular smooth muscle contraction (1)
- Vitamin B6 metabolism (1)
- aspartate and glutamate metabolism (1)
- beta-Alanine metabolism (1)
- leucine and isoleucine degradation (1)